In a regulatory filing, UnitedHealth (UNH) Group disclosed that the company proactively reached out to the Department of Justice after reviewing media reports about investigations into certain aspects of the company’s participation in the Medicare program. “The company has now begun complying with formal criminal and civil requests from the Department. The company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process. The company has a long record of responsible conduct and effective compliance. Independent CMS audits confirm that the company’s practices are among the most accurate in the industry, and, following a decade-long civil challenge by the Department to aspects of our Medicare Advantage business, a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing. To provide our stakeholders transparency and confidence in the company’s practices, the company, as previously announced, has proactively launched its own initiative to conduct third party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services. The company is committed to maintaining the integrity of its business practices and serving as reliable stewards of American tax dollars,” UnitedHealth stated.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- Bullish flow in UnitedHealth with shares up 1.02%
- Deutsche Bank Slashes UnitedHealth Stock (UNH) Price Target Ahead of Q2 Earnings
- UnitedHealth price target lowered to $328 from $362 at Deutsche Bank
- UnitedHealth Stock Collapse Continues: Here’s What This Investor Thinks Will Happen Next
